Skip to content
Governance Register

← US public companies

Fulcrum Therapeutics, Inc.

SEC CIK 1680581 · FULC · last insider filing 2026-06-30

Directors (from insider filings)

NameCapacity as filedFilings
Ezekowitz Alan Director filed 2019 - 2026
Lehrer-Graiwer Joshua Director filed 2026 - 2026
Gould Robert J Director · See Remarks filed 2019 - 2026
Sapir Alex Director · See Remarks filed 2023 - 2026
Geraghty James A Director filed 2019 - 2025
King Rachel K. Director filed 2024 - 2025
Dorton Katina Director filed 2020 - 2025
Haviland Kate Director filed 2019 - 2025
Hill Colin Director filed 2024 - 2025
Banks Sonja Director filed 2021 - 2025
Collins James J. Director filed 2019 - 2024
Stuart Bryan Director · See Remarks filed 2019 - 2022
Levin Mark J Director filed 2019 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Musso Alan A Chief Financial Officer filed 2023 - 2026
Oltmans Curtis Gale SVP, General Counsel filed 2020 - 2026
Tourangeau Greg Vice President, Finance filed 2022 - 2026
Horn Patrick Taylor Chief Medical Officer filed 2024 - 2024
Hayes Melvin H. III Chief Operating Officer filed 2022 - 2023
Rajavelu Esther Chief Financial Officer filed 2022 - 2023
Arroyo Santiago Chief Medical Officer filed 2022 - 2022
Thomson Peter G. VP Finance & Accounting filed 2019 - 2022
Dunn Judith See Remarks filed 2021 - 2022
Morabito Christopher Chief Medical Officer filed 2021 - 2022
Moxham Christopher Chief Scientific Officer filed 2021 - 2021
Wallace Owen B. Chief Scientific Officer filed 2019 - 2020
Cadavid Diego See Remarks filed 2019 - 2020

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.